See every side of every news story

Browser Extension

Saturday, April 19, 2025

US Edition

Subscribe Login

Israel-Hamas Conflict

Natural Disasters

Catholic Church

Artificial Intelligence

cannadelics.com image

News from cannadelics.com

News Home Page Local News Blindspot Feed International Covid-19

International North America South America Europe Asia Australia Africa

Trending Internationally Social Media WWE Baseball Donald Trump Natural Disasters

Trending in U.S.Israel-Hamas Conflict Baseball US Politics Donald Trump US Immigration

Trending in U.K.Israel-Hamas Conflict Premier League Manchester United Soccer Manchester City

Trending Topics

Social Media WWE Baseball Donald Trump Israel-Hamas Conflict

CompanyAbout History Mission Blog Testimonials Group Subscriptions Subscribe Gift Free Trial Careers Affiliates

HelpHelp Center FAQ Contact Us For Educators/Libraries Media Bias Ratings Ownership and Factuality Ratings Referral Code News Sources Topics

ToolsApp Browser Extension Daily Newsletter Blindspot Report Newsletter Burst Your Bubble Newsletter Timelines

Gift Privacy Policy Manage Cookies Terms and Conditions

© 2025 Snapwise Inc

Search Blindspot Local

News from cannadelics.com

See all of cannadelics.com’s headline news. Compare how the top news stories are covered by left-wing and right-wing news sources.

Ground News has come across 10 headlines reported on by cannadelics.com during the past 3 months.

We’ve assigned a media bias rating of to cannadelics.com. You can read more about our methodology here.

cannadelics.com’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

See all of cannadelics.com’s headline news. Compare how the top news stories are covered by left-wing and right-wing news sources. Ground News has come across 10 headlines reported on by cannadelics.com during the past 3 months.

We’ve assigned a media bias rating of to cannadelics.com. You can read more about our methodology here. cannadelics.com’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about cannadelics.com

Where is cannadelics.com located?cannadelics.com's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top cannadelics.com News

Jobs, Salaries, and Opportunities (2025)

Psychedelic Drugs · Portland

Jobs, Salaries, and Opportunities (2025)

Introduction The psilocybin industry is evolving quickly—from fringe advocacy to a multibillion-dollar wellness and medical ecosystem. With legal frameworks in Oregon, Colorado, and other states soon to follow, new careers are opening in cultivation, clinical care, compliance, education, and technology. Whether you’re looking to become a frontline facilitator or want to support psychedelic access behind the scenes, this guide outlines the top ca…See the Story

Neuralink, Blackrock, Synchron or ELVIS: Who’s Leading the BCI Race? - Cannabis News World

BlackRock · Russia

Neuralink, Blackrock, Synchron or ELVIS: Who’s Leading the BCI Race? - Cannabis News World

How ELVIS Technologies compares to Neuralink, Blackrock Neurotech, and Synchron in the fast-evolving BCI Race (brain-computer interface). The post Neuralink, Blackrock, Synchron or ELVIS: Who’s Leading the BCI Race? appeared first on Cannadelics.See the Story

You've scrolled to the bottom of the feed, there are no more stories.

How to Get Legal Psilocybin Capsules? - Cannadelics

United States · United States

How to Get Legal Psilocybin Capsules? - Cannadelics

Looking for a Legal Way to Experience Psilocybin Capsules? Psilocybin capsules provide a precise, convenient, and taste-free way to experience magic mushrooms. They are ideal for microdosing, controlled experiences, and therapeutic use. However, finding a legal way to obtain psilocybin capsules can be difficult—unless you know the right way. The only 100% legal way to obtain psilocybin capsules in the U.S. is through a recognized psychedelic chu…See the Story

Magic Mushrooms: Do They Really Have Legitimate Therapeutic Purposes?

United States · United States

Magic Mushrooms: Do They Really Have Legitimate Therapeutic Purposes?

There have been many substances over the years that the federal government feels should have an illegal designation. However, not all of them seem to have quite the devastating effects that propaganda films would have you believe. For instance, you only have to look at movies like Reefer Madness to see the outsized hysteria that […]See the Story

Microdosing with James Fadiman and Jordan Gruber

Psychedelic Drugs

Microdosing with James Fadiman and Jordan Gruber

Microdosing involves taking very small amounts of psychedelic substances such as LSD or psilocybin, maybe seven to twelve percent of a regular dose. It’s not enough to “trip out” but enough, proponents say, to yield very positive results, especially in terms of treating depression that hasn’t responded well to other methods. The catalog of extensive clinical, scientific trials about the practice… SourceSee the Story

New Connecticut Bill Would Decriminalize Psilocybin

Psychedelic Drugs · Oregon

New Connecticut Bill Would Decriminalize Psilocybin

A bill introduced in the Connecticut General Assembly by would decriminalize possession of small amounts of psilocybin, the psychoactive compound found in magic mushrooms. House Bill 7065, sponsored by the Joint Committee on Judiciary, would remove criminal penalties for individuals found in possession of less than half an ounce of psilocybin. Under the bill, first-time … Continue readingSee the Story